Law360, New York (October 06, 2010, 7:36 PM ET) -- A federal judge has refused to sign off on a $45 million settlement between medical technology company Becton Dickinson & Co. and distributors who alleged the firm violated antitrust laws when it sold hypodermic products.
Becton Dickinson disclosed the setback Wednesday in a regulatory filing with the U.S. Securities and Exchange Commission. Judge Jose L. Linares of the U.S. District Court for the District of New Jersey issued the order on Sept. 30.
The settlement would have ended federal antitrust claims brought against Becton Dickinson by...
Court Denies $45M Deal To End BD Class Action
To view the full article, take a free trial now.
